RSS feed

Publications by Arne Svilaas

31 publications found

Original articles

Svilaas A, Røsbø PO, Høye K (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (1)
DOI 10.4045/tidsskr.23.0750, PubMed 38258720

Pope MK, Atar D, Svilaas A, Hole T, Nielsen JD, Hintze U, Crisby M, Raatikainen P, Airaksinen KEJ, Virdone S, Pieper K, Kayani G, Le Heuzey JY, Steffel J, Stepinska J, Bassand JP, Camm AJ, GARFIELD-AF Investigators (2021)
Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
Ann Med, 53 (1), 485-494
DOI 10.1080/07853890.2021.1893897, PubMed 33818226

Arnesen KE, Phung AV, Randsborg K, Mork I, Thorvall M, Langslet G, Svilaas A, Wium C, Ose L, Retterstøl K (2021)
Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study
Front Pharmacol, 11, 560958
DOI 10.3389/fphar.2020.560958, PubMed 33737874

Hovland A, Narverud I, Lie Øyri LK, Bogsrud MP, Aagnes I, Ueland T, Mulder M, Leijten F, Langslet G, Wium C, Svilaas A, Arnesen KE, Roeters van Lennep J, Aukrust P, Halvorsen B, Retterstøl K, Holven KB (2020)
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers
J Clin Lipidol, 15 (1), 134-141
DOI 10.1016/j.jacl.2020.12.006, PubMed 33358307

Bogsrud MP, Langslet G, Wium C, Johansen D, Svilaas A, Holven KB (2017)
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
J Clin Lipidol, 12 (2), 375-382
DOI 10.1016/j.jacl.2017.11.009, PubMed 29310990

Christensen JJ, Osnes LT, Halvorsen B, Retterstøl K, Bogsrud MP, Wium C, Svilaas A, Narverud I, Ulven SM, Aukrust P, Holven KB (2016)
Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia
Atherosclerosis, 256, 67-74
DOI 10.1016/j.atherosclerosis.2016.11.031, PubMed 28024183

Torvik K, Narverud I, Ottestad I, Svilaas A, Gran JM, Retterstøl K, Ellingvåg A, Strøm E, Ose L, Veierød MB, Holven KB (2016)
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia
Atherosclerosis, 252, 21-27
DOI 10.1016/j.atherosclerosis.2016.07.913, PubMed 27494447

Molven I, Retterstøl K, Andersen LF, Veierød MB, Narverud I, Ose L, Svilaas A, Wandel M, Holven KB (2013)
Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
J Nutr Sci, 2, e32
DOI 10.1017/jns.2013.27, PubMed 25191582

Svilaas A, Strøm EC, Johansen SG, Vebenstad G, Svilaas T, Ose L (2011)
[Assessment of dietary habits and life style]
Tidsskr Nor Laegeforen, 131 (5), 454
DOI 10.4045/tidsskr.10.0799, PubMed 21383795

Sakhi AK, Bøhn SK, Smeland S, Thoresen M, Smedshaug GB, Tausjø J, Svilaas A, Karlsen A, Russnes KM, Svilaas T, Blomhoff R (2010)
Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma
Nutr Cancer, 62 (3), 322-8
DOI 10.1080/01635580903441188, PubMed 20358469

Svilaas A, Strandberg T, Eriksson M, Hildebrandt P, Westheim A (2008)
Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia
Scand Cardiovasc J, 42 (4), 279-87
DOI 10.1080/14017430802073073, PubMed 18609053

Bøhn SK, Smeland S, Sakhi AK, Thoresen M, Russnes KM, Tausjø J, Svilaas A, Svilaas T, Blomhoff R (2005)
Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma
Cancer Lett, 238 (2), 240-7
DOI 10.1016/j.canlet.2005.07.027, PubMed 16157445

Svilaas A, Kjeldsen SE, Midtbø K, Westheim A, Syvertsen JO (2004)
[Prevention of myocardial infarction and stroke with statins]
Tidsskr Nor Laegeforen, 124 (13-14), 1821
PubMed 15229678

Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Ström EC, Jacobs DR, Ose L, Blomhoff R (2004)
Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans
J Nutr, 134 (3), 562-7
DOI 10.1093/jn/134.3.562, PubMed 14988447

Svilaas A, Kjeldsen S, Midtbø K, Westheim A, Syvertsen JO (2004)
[Statin therapy for hypertensive patients]
Tidsskr Nor Laegeforen, 124 (2), 165-6
PubMed 14743227

Svilaas A, Ström EC, Svilaas T, Borgejordet A, Thoresen M, Ose L (2002)
Reproducibility and validity of a short food questionnaire for the assessment of dietary habits
Nutr Metab Cardiovasc Dis, 12 (2), 60-70
PubMed 12189905

Holven KB, Holm T, Aukrust P, Christensen B, Kjekshus J, Andreassen AK, Gullestad L, Hagve TA, Svilaas A, Ose L, Nenseter MS (2001)
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
Am J Med, 110 (7), 536-42
DOI 10.1016/s0002-9343(01)00696-9, PubMed 11343667

Svilaas A, Ose L, Risberg K, Thoresen M (2001)
[Treatment goals for blood lipids in high risk patients of atherosclerotic disease]
Tidsskr Nor Laegeforen, 121 (9), 1059-63
PubMed 11354882

Svilaas A, Risberg K, Thoresen M, Ose L (2000)
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice
Am J Cardiol, 86 (11), 1250-3, A6
DOI 10.1016/s0002-9149(00)01212-1, PubMed 11090801

Svilaas A, Thoresen M, Kristoffersen JE, Hjartaaker J, Westheim A (2000)
How well are patients with atherosclerotic disease treated? Secondary prevention in primary care
Scand J Prim Health Care, 18 (4), 232-6
DOI 10.1080/028134300448805, PubMed 11205092

Svilaas A, Bergei CS, Strøm EC, Ose L, Walsøe HK (2000)
[The diet of patients with atherosclerotic disease compared with the standard diet in the population]
Tidsskr Nor Laegeforen, 120 (22), 2618-24
PubMed 11077504

Svilaas A, Walsöe HK, Ose L (2000)
Application of simple lipid treatment goals in patients with atherosclerotic disease
Nutr Metab Cardiovasc Dis, 10 (2), 71-8
PubMed 10919171

Svilaas A, Westheim A, Kristoffersen JE, Hjartaaker J, Thoresen M (1998)
[How well are patients with atherosclerosis treated in general practice? Risk factors and intervention surveyed in 1996-97 as compared to two previous years]
Tidsskr Nor Laegeforen, 118 (15), 2308-13
PubMed 9691796

Svilaas A, Bye P, Strøm EC, Kolbjørnsen O, Tonstad S, Ose L (1997)
[What happens with patients after participation in a clinical trial?]
Tidsskr Nor Laegeforen, 117 (28), 4065-9
PubMed 9441437

Svilaas A, Westheim A, Kristoffersen JE, Hjartaaker J (1996)
[Risk factors and intervention in cardiovascular diseases in general practice]
Tidsskr Nor Laegeforen, 116 (21), 2562-5
PubMed 8928126

Review articles

Fretheim A, Odgaard-Jensen J, Brørs O, Madsen S, Njølstad I, Norheim OF, Svilaas A, Kristiansen IS, Thürmer H, Flottorp S (2012)
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
BMC Med, 10, 33
DOI 10.1186/1741-7015-10-33, PubMed 22480336

Other articles

Langslet G, Bogsrud MP, Wium C, Johansen D, Svilaas A, Holven KB (2018)
Some children with a familial hypercholesterolemia mutation may exhibit persistent low LDL levels
J Clin Lipidol, 12 (5), 1327-1328
DOI 10.1016/j.jacl.2018.06.012, PubMed 30033003

Christensen JJ, Osnes L, Halvorsen B, Retterstøl K, Bogsrud MP, Wium C, Svilaas A, Narverud I, Ulven SM, Aukrust P, Holven KB (2016)
Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
Data Brief, 10, 587-592
DOI 10.1016/j.dib.2016.12.042, PubMed 28070551

Barrett-Connor E, de Gaetano G, Djoussé L, Ellison RC, Estruch R, Finkel H, Goldfinger T, Keil U, Lanzmann-Petithory D, Mattivi F, Skovenborg E, Stockley C, Svilaas A, Teissedre PL, Thelle DS, Ursini F, Waterhouse AL (2016)
Comments on Moderate Alcohol Consumption and Mortality
J Stud Alcohol Drugs, 77 (5), 834-6
DOI 10.15288/jsad.2016.77.834, PubMed 27588543

Books

Svilaas A (2007)
Fett
Novartis Norge, Oslo ([3. utg.]), 31 s.
BIBSYS 08035257x

Theses

Svilaas A (2003)
Intervention on risk factors for atherosclerotic disease in general practice
In Hjerteforum, Supplement, Norsk cardiologisk selskap, Oslo, 5, 2003, 116 s.
BIBSYS 03177329x